📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's disease. (2025)

First Author: Fertan E

Attributed to: The Mechanisms Of The Cellular Phase Of Alzheimer's Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/alz.70086

PubMed Identifier: 40237235

Publication URI: http://europepmc.org/abstract/MED/40237235

Type: Journal Article/Review

Volume: 21

Parent Publication: Alzheimer's & dementia : the journal of the Alzheimer's Association

Issue: 4

ISSN: 1552-5260